HIV Infections
📧 Sign up to get email alerts when something new happens for HIV Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-08-28Clinical Trial Results: Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting [NA]
A completed clinical trial evaluating a dual Point-of-Care screening approach for syphilis in a low-resource setting, with results posted.
-
EMA approval · 2026-08-20EMA Authorised: Epivir (lamivudine) — ViiV Healthcare BV
Epivir (lamivudine) has been authorised by EMA for HIV infections.
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: Mobilizing Social Network Resources for HIV Care Support [NA]
A completed clinical trial evaluating mobilizing social network resources to support HIV care.
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Results: AmbassADDOrs for Health Study [NA]
A terminated clinical trial (NCT05357144) conducted by UCSF for HIV infections with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-19Clinical Trial Results: SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs [NA]
Completed clinical trial evaluating an integrated hospital model to optimize HIV prevention among people who inject drugs; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Skills to Empower Affirmative Men [NA]
Completed clinical trial results for a study focusing on skills to empower affirmative men; conditions include bisexuality, homosexuality, a…
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: HIV Prevention Peer Navigation for Justice Involved Women [NA]
Completed clinical trial examining HIV prevention peer navigation for justice-involved women; results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: Start the Conversation: Evaluating Implementation of a Multi-level PrEP Initiative for Black Cisgender Women in Nola [NA]
Completed clinical trial evaluating a multi-level PrEP implementation initiative for Black cisgender women; results posted.
-
EMA approval · 2026-07-08EMA Authorised: Ritonavir Viatris (previously Ritonavir Mylan) (ritonavir) — Viatris Limited
Ritonavir Viatris (ritonavir) has been authorised in the EU for HIV infections.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy [NA]
Study results on the effects of transcutaneous electrical nerve stimulation (TENS) and mindfulness meditation in HIV-related neuropathy have…
-
EMA withdrawal · 2026-07-01EMA Withdrawn: Stocrin (efavirenz) — Merck Sharp & Dohme B.V.
EMA has withdrawn Stocrin (efavirenz) from the market in the EU.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED) [Phase 4]
Phase 4 trial evaluating a simplified linkage and retention to care model with a mobile unit and same-day test-and-treat for people excluded…
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: Impact of a Telenovela/Soap Opera for HIV Prevention in Latinas [NA]
Completed clinical trial assessing a telenovela/soap opera intervention for HIV prevention among Latinas; results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: The Women TDF-FTC Benchmark Study [Phase 2]
Phase 2 trial results for Women TDF-FTC Benchmark Study in HIV infections have been completed with results posted.
-
EMA approval · 2026-06-12EMA Authorised: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine;tenofovir disoproxil maleate) — Mylan Pharmaceuticals Limited
Emtricitabine/tenofovir disoproxil Mylan has been authorised for use in HIV infections in the EU.
-
EMA approval · 2026-06-11EMA Authorised: Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate) — Zentiva k.s.
A European Medicines Agency authorisation for Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate) for HIV infections.
-
EMA approval · 2026-04-28EMA Authorised: Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan) (lopinavir;ritonavir) — Viatris Limited
The EMA has authorised Lopinavir/Ritonavir Viatris (lopinavir/ritonavir) for HIV infections.
-
EMA approval · 2026-04-23EMA Authorised: Aptivus (tipranavir) — Boehringer Ingelheim International GmbH
The European Medicines Agency authorised Aptivus (tipranavir) by Boehringer Ingelheim International GmbH for HIV infections (status: authori…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta [NA]
Clinical trial update indicates a study aimed at integrating supports to promote pre-exposure prophylaxis (PrEP) use among Black adolescents…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: PASEO Intervention for Adolescents Transitioning to Adult HIV Care in Urban Peru [NA]
This document provides a status update on the PASEO Intervention trial, which evaluates an HIV care transition program for adolescents movin…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants. [Phase 1]
Phase 1 study evaluating safety and immunogenicity of a stabilized CH505 TF HIV envelope trimer vaccine in healthy, HIV-uninfected adults; r…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants [Phase 1]
A Phase 1 study evaluated pharmacokinetics, safety, and tolerability of two long-acting cabotegravir formulations in healthy adult participa…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Developing a Chatbot to Promote HIV Testing [NA]
A Yale University–sponsored study is developing a chatbot to promote HIV testing; the trial is currently not yet recruiting.
-
EMA approval · 2026-01-28EMA Authorised: Biktarvy (bictegravir;emtricitabine;tenofovir alafenamide;fumarate) — Gilead Sciences Ireland UC
The EMA has authorized Biktarvy for HIV infections, with Gilead Sciences Ireland UC as the marketing authorization holder.
-
EMA approval · 2026-01-07EMA Authorised: Norvir (ritonavir) — AbbVie Deutschland GmbH & Co. KG
Norvir (ritonavir) has been authorised in the EU for HIV infections; the marketing authorization holder is AbbVie Deutschland GmbH & Co. KG.